Five millennia of Bartonella quintana bacteraemia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 15 03 2020
accepted: 09 09 2020
entrez: 4 11 2020
pubmed: 5 11 2020
medline: 29 12 2020
Statut: epublish

Résumé

During the two World Wars, Bartonella quintana was responsible for trench fever and is now recognised as an agent of re-emerging infection. Many reports have indicated widespread B. quintana exposure since the 1990s. In order to evaluate its prevalence in ancient populations, we used real-time PCR to detect B. quintana DNA in 400 teeth collected from 145 individuals dating from the 1st to 19th centuries in nine archaeological sites, with the presence of negative controls. Fisher's exact test was used to compare the prevalence of B. quintana in civil and military populations. B. quintana DNA was confirmed in a total of 28/145 (19.3%) individuals, comprising 78 citizens and 67 soldiers, 20.1% and 17.9% of which were positive for B. quintana bacteraemia, respectively. This study analysed previous studies on these ancient samples and showed that the presence of B. quintana infection followed the course of time in human history; a total of 14/15 sites from five European countries had a positive prevalence. The positive rate in soldiers was higher than those of civilians, with 20% and 18.8%, respectively, in the 18th and 19th centuries, but the difference in frequency was not significant. These results confirmed the role of dental pulp in diagnosing B. quintana bacteraemia in ancient populations and showed the incidence of B. quintana in both civilians and soldiers.

Identifiants

pubmed: 33147255
doi: 10.1371/journal.pone.0239526
pii: PONE-D-20-07460
pmc: PMC7641340
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0239526

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Microbiol Rev. 1996 Jul;9(3):273-92
pubmed: 8809460
Emerg Infect Dis. 2013 Feb;19(2):297-300
pubmed: 23347418
Emerg Infect Dis. 2005 Nov;11(11):1742-4
pubmed: 16318727
Microbes Infect. 2015 Nov-Dec;17(11-12):879-83
pubmed: 26369716
Emerg Infect Dis. 2006 Dec;12(12):1869-72
pubmed: 17326937
Clin Infect Dis. 1999 Aug;29(2):434-6
pubmed: 10476755
PLoS One. 2010 Oct 27;5(10):e15405
pubmed: 21060879
Emerg Infect Dis. 2011 Sep;17(9):1707-9
pubmed: 21888799
PLoS Negl Trop Dis. 2015 Jan 15;9(1):e0003467
pubmed: 25590435
Eur J Clin Microbiol Infect Dis. 2004 Dec;23(12):920-2
pubmed: 15558347
Jpn J Infect Dis. 2006 Feb;59(1):31-5
pubmed: 16495631
Annu Rev Microbiol. 2019 Sep 8;73:639-666
pubmed: 31283430
Clin Infect Dis. 2000 Jul;31(1):131-5
pubmed: 10913410
N Engl J Med. 1999 Jan 21;340(3):184-9
pubmed: 9895398
J Am Acad Dermatol. 2001 Feb;44(2):219-23
pubmed: 11174378
PLoS One. 2011 Mar 10;6(3):e16735
pubmed: 21423736
J Infect Dis. 2005 Feb 15;191(4):607-11
pubmed: 15655785
Parasit Vectors. 2017 Nov 7;10(1):553
pubmed: 29116007
N Engl J Med. 1995 Feb 16;332(7):419-23
pubmed: 7529894
Emerg Infect Dis. 2003 Mar;9(3):338-42
pubmed: 12643829
Mol Ecol. 2014 Mar;23(5):1204-12
pubmed: 24400877
Clin Infect Dis. 2002 Sep 15;35(6):684-9
pubmed: 12203165
Lancet Infect Dis. 2016 Aug;16(8):e164-72
pubmed: 27375211
Int J Antimicrob Agents. 2014 Jul;44(1):16-25
pubmed: 24933445
Mol Genet Genomic Med. 2020 Jun;8(6):e1202
pubmed: 32233019
Emerg Infect Dis. 2006 Feb;12(2):217-23
pubmed: 16494745
Ticks Tick Borne Dis. 2016 Jul;7(5):763-767
pubmed: 26997137
Medicine (Baltimore). 2005 Jan;84(1):61-8
pubmed: 15643300
Mem Inst Oswaldo Cruz. 2005 Dec;100(8):853-9
pubmed: 16444416
PLoS One. 2014 Feb 28;9(2):e88376
pubmed: 24586319
J Infect Dis. 2006 Jan 1;193(1):112-20
pubmed: 16323139
Am J Phys Anthropol. 2011 Jul;145(3):489-94
pubmed: 21541920
J Clin Microbiol. 2007 Jan;45(1):270-2
pubmed: 17093037
Emerg Infect Dis. 2005 Aug;11(8):1287-9
pubmed: 16102321
Emerg Infect Dis. 2015 Dec;21(12):2168-70
pubmed: 26584238
Am J Phys Anthropol. 2011 Sep;146(1):134-7
pubmed: 21710687
Clin Microbiol Infect. 1997 Feb;3(6):692-695
pubmed: 11864215
Methods Mol Biol. 2012;840:13-9
pubmed: 22237516
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12637-40
pubmed: 9770538
J R Soc Med. 2006 Nov;99(11):564-8
pubmed: 17082300
Clin Anat. 2016 Oct;29(7):816-22
pubmed: 26940256

Auteurs

Ba-Hoang-Anh Mai (BH)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique-Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEPHI), Institut Hospitalo-Universitaire (IHU)-Méditerranée Infection, Marseille, France.
Hue University of Medicine and Pharmacy, Hue, Vietnam.

Rémi Barbieri (R)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique-Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEPHI), Institut Hospitalo-Universitaire (IHU)-Méditerranée Infection, Marseille, France.

Thomas Chenal (T)

CNRS, UMR 6298 ArTeHiS, France.

Dominique Castex (D)

UMR 5199 du CNRS, PACEA, Anthropologie des Populations Passées et Présentes, Université de Bordeaux, Pessac, France.

Richard Jonvel (R)

Amiens Métropole Service Archéologie Préventive, France.

Davide Tanasi (D)

Department of History, University of South Florida, Tampa, Florida, United States of America.

Patrice Georges-Zimmermann (P)

INRAP, UMR 5608 CNRS, TRACES, France.

Olivier Dutour (O)

Ecole Pratique des Hautes Etudes, Université Paris Sciences Lettres-UMR 5199 CNRS, PACEA, Université de Bordeaux, Pessac, France.

David Peressinotto (D)

UMR 5199 du CNRS, PACEA, Anthropologie des Populations Passées et Présentes, Université de Bordeaux, Pessac, France.
HADES- Bureau d'investigation archéologiques, Bordeaux, France.

Coralie Demangeot (C)

UMR 5199 du CNRS, PACEA, Anthropologie des Populations Passées et Présentes, Université de Bordeaux, Pessac, France.
HADES- Bureau d'investigation archéologiques, Bordeaux, France.

Michel Drancourt (M)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique-Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEPHI), Institut Hospitalo-Universitaire (IHU)-Méditerranée Infection, Marseille, France.

Gérard Aboudharam (G)

Aix-Marseille Université UM63, Institut de Recherche pour le Développement IRD 198, Assistance Publique-Hôpitaux de Marseille (AP-HM), Microbes, Evolution, Phylogeny and Infection (MEPHI), Institut Hospitalo-Universitaire (IHU)-Méditerranée Infection, Marseille, France.
UFR Odontologie, Aix-Marseille Université, Marseille, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH